Valuation: RaySearch Laboratories AB

Market Cap 6.62B 678M 605M 554M 505M 948M 64.33B 968M 2.67B 33.87B 2.54B 2.49B 108B P/E 2026 *
26x
P/E 2027 * 20.9x
Enterprise Value 6.79B 695M 620M 568M 518M 972M 65.94B 992M 2.74B 34.72B 2.61B 2.55B 110B EV / Sales 2026 *
4.91x
EV / Sales 2027 * 4.12x
Free-Float
80.09%
Yield 2026 *
1.97%
Yield 2027 * 2.22%
1 day-2.86%
1 week+2.66%
Current month-2.86%
1 month+6.95%
3 months+9.93%
6 months+4.40%
Current year-13.60%
1 week 191.1
Extreme 191.1
203.8
1 month 180.6
Extreme 180.6
203.8
Current year 153.1
Extreme 153.1
238.4
1 year 153.1
Extreme 153.1
264.5
3 years 84.1
Extreme 84.1
373.5
5 years 40
Extreme 40
373.5
10 years 40
Extreme 40
373.5
Manager TitleAgeSince
Chief Executive Officer 57 1999-12-31
Director of Finance/CFO 48 2025-01-26
Chief Tech/Sci/R&D Officer 53 2015-08-27
Director TitleAgeSince
Director/Board Member 57 1999-12-31
Chairman 81 2016-11-17
Chairman 87 2022-09-29
Date Insider Type Main position Quantity % Market Cap. Importance
8/18/26 Sell

Chief Technology Officer

-3,203 0.0104%
8/17/26 Sell

Chief Technology Officer

-2,297 0.0075%
6/11/26 Buy

General Counsel

462 0.0015%
Change 5-day change 1-year change 3-year change Capi.($)
-2.86%+2.66%-12.05%+137.92% 694M
-2.06%+1.31%+20.31%+54.76% 258B
-1.83%-1.10%+5.85%+19.98% 163B
+1.12%-3.41%-18.23%+61.53% 150B
+5.57%-3.00%-56.00%-14.21% 60.84B
+1.19%+3.68%-10.64%-6.77% 53.31B
+1.36%+4.70%+13.11%+46.11% 53.03B
-1.90%-4.97%+5.43%+64.13% 50.67B
-1.65%-0.62%+17.51%+67.21% 49.3B
-2.85%-0.91%+28.58%+86.65% 45.46B
Average -0.44%+0.29%-0.61%+51.73% 88.47B
Weighted average by Cap. -0.65%+0.16%+2.96%+43.45%

Financials

2026 *2027 *
Net sales 1.38B 142M 126M 116M 105M 198M 13.43B 202M 557M 7.07B 531M 520M 22.49B 1.61B 165M 148M 135M 123M 231M 15.68B 236M 651M 8.26B 620M 607M 26.27B
Net income 266M 27.18M 24.26M 22.22M 20.26M 38M 2.58B 38.81M 107M 1.36B 102M 99.82M 4.32B 328M 33.58M 29.97M 27.46M 25.03M 46.94M 3.19B 47.94M 132M 1.68B 126M 123M 5.34B
Net Debt 166M 16.99M 15.17M 13.9M 12.67M 23.76M 1.61B 24.26M 66.92M 849M 63.75M 62.41M 2.7B 33M 3.38M 3.02M 2.76M 2.52M 4.72M 321M 4.82M 13.3M 169M 12.67M 12.41M 537M
Projected Income Statement - Annual - RaySearch Laboratories AB
Logo RaySearch Laboratories AB
RaySearch Laboratories AB (publ) is a Sweden-based medical technology company that develops software for radiation therapy of cancer. It markets and sells its products mainly in the United States and in Europe through license agreements with medical technology companies and scientific institutions. Additionally, its solutions include software for optimizing Intensity Modulated Radiation Therapy (IMRT) plans for photons, adaptive technology for IMRT treatments and software for proton treatments. The Company’s commercial partners are Philips, Nucletron and IBA Dosimetry, among others. In April 2014, it established a German subsidiary, RaySearch Germany GmbH.
Employees
464
Date Price Change Volume
26-11-02 SEK 197.00 -2.86% 155,961
26-10-30 SEK 202.80 +0.20% 51,949
26-10-29 SEK 202.40 +2.22% 91,185
26-10-28 SEK 198.00 +0.15% 101,252
26-10-27 SEK 197.70 +2.59% 87,278
Trader
Investor
Global
Quality
ESG MSCI
CCC
MarketScreener Ratings - RaySearch Laboratories AB
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
1
Last Close Price
197.00SEK
Average target price
297.50SEK
Spread / Average Target
+51.02%

Quarterly revenue - Rate of surprise

Rate of surprise - Net sales - Quarterly - RaySearch Laboratories AB
  1. Stock Market
  2. Stocks
  3. RAY B Stock